| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |